Save information for later
Sign Up

Learn About Ciliary Dyskinesia-Bronchiectasis

What is the definition of Ciliary Dyskinesia-Bronchiectasis?
Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by chronic respiratory tract infections. In individuals with primary ciliary dyskinesia, the tiny hair-like structures (cilia) that protect the lungs and other tissues have mutations that prevent them from working properly, eventually leading to a condition where the bronchial tubes in the lungs are permanently damaged (bronchiectasis).
What are the symptoms of Ciliary Dyskinesia-Bronchiectasis?
Symptoms of primary ciliary dyskinesia include a persistent wet cough from birth or infancy, neonatal respiratory distress, shortness of breath, wheezing or whistling upon breathing, recurrent chest colds, asthma, chronic nasal drainage, hearing problems, and chronic infections in the ears, sinuses, and lungs that eventually lead to the development of bronchiectasis (permanent bronchial tube damage). Additional symptoms may include infertility or a condition where organs, such as the heart, liver, or other organs, are either reversed in the body (situs inversus) or abnormally formed.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Ciliary Dyskinesia-Bronchiectasis?
While there is no cure for primary ciliary dyskinesia, treatment is focused on alleviating symptoms and may include antibiotics for sinus or lung infections, bronchodilators, steroids, and mucous thinners (mucolytics), oxygen therapy, airway clearance techniques, speech therapy, hearing aids, and physical therapy. Surgery may be necessary to correct any heart defects, while lung transplantation may be considered for patients with severe, advanced bronchiectasis (permanently damaged bronchial tubes).
Who are the top Ciliary Dyskinesia-Bronchiectasis Local Doctors?
Sharon D. Dell
Elite in Ciliary Dyskinesia-Bronchiectasis
Elite in Ciliary Dyskinesia-Bronchiectasis
Vancouver, BC, CA 

Sharon Dell practices in Vancouver, Canada. Dell is rated as an Elite expert by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. Their top areas of expertise are Ciliary Dyskinesia-Bronchiectasis, Drug Induced Dyskinesia, Situs Inversus, and Dextrocardia with Situs Inversus.

Michael R. Loebinger
Elite in Ciliary Dyskinesia-Bronchiectasis
Elite in Ciliary Dyskinesia-Bronchiectasis
London, ENG, GB 

Michael Loebinger practices in London, United Kingdom. Mr. Loebinger is rated as an Elite expert by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. His top areas of expertise are Bronchiectasis, Ciliary Dyskinesia-Bronchiectasis, Drug Induced Dyskinesia, and Situs Inversus.

 
 
 
 
Learn about our expert tiers
Learn More
Tobias Welte
Elite in Ciliary Dyskinesia-Bronchiectasis
Elite in Ciliary Dyskinesia-Bronchiectasis
Carl Neuberg Str. 1, 
Hannover, NI, DE 

Tobias Welte practices in Hannover, Germany. Mr. Welte is rated as an Elite expert by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. His top areas of expertise are Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Lung Transplant, and Endoscopy.

What are the latest Ciliary Dyskinesia-Bronchiectasis Clinical Trials?
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)

Summary: The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.

Match to trials
Find the right clinical trials for you in under a minute
Get started
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping

Objective: To identify molecular endotypes of bronchiectasis that accurately predict prognosis and guide treatment responses. Secondary